GlassScriptPhysician profile
Steven M Nash
NPI 1346324738
$700.02
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $652 · 2021: $28.75 · 2024: $19.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $94.22 | 2020 | |
| Acadia Pharmaceuticals INC | $63.08 | 2020 | |
| Sunovion Pharmaceuticals INC. | $60.13 | 2020 | |
| Lilly USA, LLC | $56.11 | 2020 | |
| Neurocrine Biosciences, INC. | $48.67 | 2020 | |
| Upsher-Smith Laboratories LLC | $35.03 | 2020-2021 | |
| Eisai INC. | $34.62 | 2020 | |
| Emd Serono, INC. | $33.18 | 2020 | |
| Amneal Pharmaceuticals LLC | $30.41 | 2020 | |
| Kyowa Kirin, INC. | $22.77 | 2020 | |
| Mallinckrodt Hospital Products INC. | $22.62 | 2020 | |
| Allergan, INC. | $20.85 | 2020 | |
| Biogen, INC. | $20.17 | 2020 | |
| Medtronic, INC. | $19.28 | 2024 | Percept PC Brainsense |
| Tanabe Pharma America, INC. | $17.38 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $16.51 | 2020 | |
| Ucb, INC. | $16.14 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.89 | 2021 | |
| Merz North America, INC. | $15.79 | 2020 | |
| Csl Behring | $15.69 | 2020 | |
| Abbvie INC. | $15.36 | 2020 | |
| Adamas Pharmaceuticals, INC. | $15.14 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $10.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Nash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.